Malaria prevention study for children in Uganda
Treatments studied
Part of Infections clinical trials.
This study tests a new way to prevent malaria in children living in Busia District, Uganda. It combines malaria vaccines with preventive medicine to see if it offers better protection than current methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child lives in Busia District, Uganda
- You (parent or guardian) can give permission for your child to join
- You agree to bring your child to the study clinic for any fever or illness
- Your child does not have sickle cell disease
- You (the biological mother) are not HIV positive
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving two malaria medicines together (dihydroartemisinin piperaquine and primaquine) to everyone in a community can help reduce malaria. It is for people living in high-risk areas in eastern Ghana.
This trial tests a new combination of experimental malaria vaccines to see if they are safe and help protect against malaria. It includes both adults and young children in malaria-affected areas.
This study tests a way to clear hidden malaria parasites in people who don't feel sick, to help stop the spread of malaria in Rwanda.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
This study tests different schedules of a malaria prevention medicine to see which works best for improving school attendance, learning, and executive function in children aged 6 to 10 in Siaya County, Kenya.
This trial tests whether giving a malaria prevention drug (DHA-PQP) to pregnant women in Kasese District can reduce malaria in pregnancy. Pregnant women at Bugoye Health Center who are less than 22 weeks along may join.
Hear when a new Malaria Falciparum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.